Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe
This study has been completed.
Study NCT00630669   Information provided by University of California, Los Angeles

First Received on February 27, 2008.   Last Updated on March 6, 2008   History of Changes

February 27, 2008
March 6, 2008
December 1997
May 2000   (final data collection date for primary outcome measure)
treatment success rate [ Time Frame: one year ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00630669 on ClinicalTrials.gov Archive Site
treatment complication rate [ Time Frame: one year ] [ Designated as safety issue: Yes ]
Same as current
 
 
 
Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe
Randomized Study Of Endoscopic Band Ligation Versus Bipolar Probe Electrocoagulation Of Bleeding Internal Hemorrhoids

The purpose of this study is to determine which treatment, band ligation (placing rubber bands around the hemorrhoids) or BICAP electrocoagulation (using electricity to cauterize) is safer and more effective endoscopic treatment for bleeding internal hemorrhoids.

 
Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Hemorrhoids
  • Procedure: Rubber band ligation
    placing rubber bands around the internal hemorrhoids
  • Procedure: Bipolar coagulation
    using electricity to cauterize
  • Active Comparator: 1
    Rubber band ligation
    Intervention: Procedure: Rubber band ligation
  • Active Comparator: 2
    Bipolar coagulation
    Intervention: Procedure: Bipolar coagulation
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
45
May 2001
May 2000   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Grade II or III internal hemorrhoids with chronic rectal bleeding, which failed at least 8 weeks of intensive medical therapy.
  2. Age over 18 years
  3. A life expectancy of at least 24 months
  4. A signed written informed consent

Exclusion Criteria:

  1. The patient was uncooperative or could not return for routine outpatient follow-up
  2. Severe or end-stage co-morbid illness
  3. Prior endoscopic or surgical treatment of hemorrhoids within the past 6 months
  4. Ongoing need for anticoagulation therapy or high doses of aspirin or non-steroidal antiinflammatory agents
  5. Presence of severe rectal pain
  6. Recently thrombosed internal or external hemorrhoids
  7. Anal stricture,fissure, fistula,or abscess
  8. Rectal carcinoma or bleeding distal colonic polyp
  9. Rectal varices
  10. Acute or chronic colitis
  11. Rectal prolapse
  12. Radiation telangiectasia of the rectum
  13. Prothrombin time >3 seconds over control
  14. Platelet count <75,000
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00630669
97-10-009-03
No
Rome Jutabha,MD/Associate Professor of Medicine, University of California, Los Angeles
University of California, Los Angeles
American Society for Gastrointestinal Endoscopy
 
University of California, Los Angeles
May 2001

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP